April 16 (Reuters) - Astellas Pharma Inc:
* CARDURION PHARMACEUTICALS LICENSES CLINICAL STAGE HEART FAILURE CANDIDATE FROM ASTELLAS
* CARDURION PHARMACEUTICALS - ENTERED EXCLUSIVE LICENSING AGREEMENT WITH ASTELLAS TO DEVELOP AND COMMERCIALIZE CRD-733 Source text for Eikon: Further company coverage: